13
Sep

2016 ASTRO Annual Meeting

The American Society for Radiation Oncology (ASTRO) Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. The 2016 Annual Meeting, taking place Sept. 25-28 at the Boston Convention and Exhibition Center, will feature research from various members of the department of radiation oncology at …

7
Sep

Teen Wraps Cancer Patients in Love

Like many teenagers, Eve Korus, 17, has a lot on her plate. The Westport, Conn. high school senior keeps busy with homework, college planning, and soccer, but she still finds time to give back to the community — especially patients undergoing chemotherapy treatment for cancer. On Aug. 30, patients and employees at the Jefferson Infusion …

11
Aug

Dr. Nicole Simone featured in Philadelphia Inquirer

It’s always important to eat wisely, even more so when you’re sick. When it comes to cancer, however, researchers are discovering tantalizing new evidence that a patient’s diet can actually help shrink tumors. Nicole Simone, a radiation oncologist at Thomas Jefferson University’s Sidney Kimmel Cancer Center, has been studying the effect of diet on standard …

10
Aug

Monica Crawford featured in Philadelphia Inquirer: Achieving good nutrition during cancer treatments

When it comes to nutrition and cancer, most information is directed toward preventing the disease. But what  if you already have cancer and are being treated for it, whether with surgery, chemotherapy, radiation therapy, or perhaps all three? Although there have been improvements in managing side effects with medications, there are still those which remain …

5
Aug

Should You Participate in a Cancer Clinical Trial? Dr. Amy Leader & Dr. Ronald Myers Discuss

Jefferson’s Amy Leader, DrPH, MPH, and Ronald Myers, PhD, of the Division of Population Science, Department of Medical Oncology, have created a tool to help patients come to terms with their own fears and preconceptions about clinical trials, in order to help them make informed decisions about their care. A recent Philadelphia Inquirer story featured …

5
Aug

SKCC and Joe Biden Receive Atlas Awards for Leadership in Fight Against Cancer

The Vice President received the 2016 Atlas Award; the Sidney Kimmel Cancer Center received 2016 Atlas Award for Leadership in the Philadelphia Area. Jefferson medical oncologist Edith Mitchell, MD, FACP, is part of a 28-member Blue Ribbon Panel appointed to inform the scientific direction and goals of the Vice President’s National Cancer Moonshot Initiative. On …

26
Jul

CMS Announces Jefferson Medical Oncology Associates Selected for Initiative Promoting Better Cancer Care

The Centers for Medicare & Medicaid Services (CMS) announced on June 29, 2016 that it has selected Jefferson Medical Oncology Associates (“Jefferson”) as one of nearly 200 physician group practices and 17 health insurance companies to participate in a care delivery model that supports and encourages higher quality, more coordinated cancer care. The Medicare arm …

25
Jul

Dr. James Posey joins the Sidney Kimmel Cancer Center

James A. Posey,III, MD, Director, Gastrointestinal Program in Medical Oncology, Co-Leader, Gastrointestinal Clinical Program at Sidney Kimmel Cancer Center, Co-Director of the Jefferson Pancreas Biliary Center Philadelphia, PA – (July 25, 2016) The Sidney Kimmel Cancer Center at Thomas Jefferson University is pleased to announce the appointment/hiring of James A. Posey III, MD as the …

19
Jul

A new tool helps remove the emotion around choosing the right approach for prostate cancer

How to Decide if Watchful Waiting is the Right Choice (PHILADELPHIA) – Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer. Although patients with localized, low-risk prostate cancer have treatment options: active surveillance, also called watchful waiting, in which …

12
Jul

Kennedy Health joins The Sidney Kimmel Cancer Network

Kennedy Health’s Cancer Center is the newest member of the Sidney Kimmel Cancer Network at Jefferson. As a cancer center network member, resources will be available to the Kennedy Cancer Center and its patients, creating local access to medical expertise, second opinions and advanced research. Learn more about the partnership. Effective July 1, Kennedy Health’s …

11
Jul

Immunotherapy for Melanoma Ignites a ‘Scientific Revolution and Promise of a Cure’

Learn more by reading a recent blog by Marlana Orloff, MD, Assistant Professor of Medical Oncology at Sidney Kimmel Medical College and researcher at Sidney Kimmel Cancer Center. “Success in melanoma has propelled the use of these drugs into many other cancers including lung, kidney, breast, pancreatic, leukemias, lymphomas, and brain, most of which remain …

29
Jun

Award of Doctor of Medical Science (Honoris Causa), University of Melbourne to Professor Richard Pestell

Dr. Pestell, was honored with the Award of Doctor of Medical Science (Honoris Causa) from the Melbourne University citing his “profound impact on the diagnosis and treatment of cancer and on the teaching, clinical, research organizations that share his determination”.  Dr. Pestell is currently one of the highest cited researcher in the world by Google …

27
Jun

Renée de Leeuw, PhD recevies 2016 Marjorie Katz Foundation–PCF Young Investigator Award

Prostate Cancer Foundation Announces 24 New Young Investigator Awards Class of 2016 Represents $5.4 Million Investment in the Future of Cancer CareSANTA MONICA, CA June 23, 2016 – The Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) Awards to pioneer increasingly precise treatments and faster cures for prostate cancer. Members …

24
Jun

Dr. Yang and Wang featured in Healio: MicroRNAs may predict risk for HCC in HBV

Circulating microRNAs may be used as noninvasive markers for predicting risk for developing hepatocellular carcinoma in patients with hepatitis B virus infection, according to recently published findings. “This research confirms previous work on microRNAs and liver cancer and goes further to show that these microRNAs may be able to predict the development of liver cancer …

Page 1 of 22